US-based company begins phase 2 human trials for Covid-19 vaccine
New York: In a ray of hope against Covid-19, Massachusetts-based biotechnology giant Moderna has commenced stage 2 trials for its new coronavirus vaccine and aims to enrol 600 participants, up…